In 2024, Kim Kelderman earned $2.29M in total compensation at Bio-Techne, including $936.00K salary and $1.32M bonus. 1+ years at the helm of Bio-Techne.
Compensation History
Annual executive compensation data for Kim Kelderman, including salary, bonuses, and stock awards.
Year
2024
Total Compensation
$2.29M
Salary
$936.00K
Bonus
$1.32M
Other
$33.47K
Salary
$936.00KBoard Justification
The Compensation Committee reviews and approves each executive’s compensation annually and is responsible for ensuring that compensation for the executive officers is consistent with four objectives: attracting and retaining superior executive talent to drive sustainable value creation, providing incentives that reward the achievement of performance goals that correlate to sustainable shareholder value, aligning executives’ incentives with long-term shareholder interests, and ensuring market competitiveness and internal equity.
Bonus
$1.32MBoard Justification
Cash performance bonuses under the Company’s Short-Term Incentive Plan based on the Company’s achievement of predetermined, objective performance targets. These challenging targets are set each year to incentivize the executives to focus on strategically important goals that directly impact the Company’s revenue and adjusted operating margin.
Other Compensation
$33.47KBoard Justification
includes $12,113 for 401(k) match, $16,890 for household security system, and $3,407 in dividends paid on unvested restricted stock, which amount was not factored into the grant date fair value of such awards.
Restricted Stock
Board Justification
N/A
Performance Metrics
For fiscal year 2025, the annual bonus plan for most of our NEOs was again based on consolidated adjusted EBITA results and consolidated organic revenue results for the Company.
Kim Kelderman
CEO of Bio-Techne
Sector of Economy
Healthcare
CEO of Bio-Techne for
1 year 10 months (Feb 2024 - Present)
Previous Experience
Executive at Thermo Fisher Scientific and a Senior Segment Leader at Becton Dickinson
Other Bio-Techne CEOs
Holdings
Track Kim Kelderman's stock holdings and portfolio value over time.
Insider Trading
Kim Kelderman's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Kim Kelderman with competitor CEOs and industry peers.
Patrick Kaltenbach
CEO of Mettler-Toledo International, Inc.
2023 Compensation
Stock
$0.00
Salary
$1.00M
Bonus
$155.16K
Other
$355.86K
Total Holdings
$7.79M
Olivier A. Filliol
CEO of Mettler-Toledo International, Inc.
2023 Compensation
Stock
$0.00
Salary
$26.67K
Bonus
$11.93K
Other
$11.93K
Total Holdings
$26.26M
Prahlad Singh
CEO of Revvity
2023 Compensation
Stock
$7.54M
Salary
$1.09M
Bonus
$0.00
Other
$32.48K
Total Holdings
$23.60M
James C. Foster
CEO of Charles River Laboratories
2023 Compensation
Stock
$0.00
Salary
$1.48M
Bonus
$1.13M
Other
$71.89K
Total Holdings
$582.93K